Heart muscle excitation-contraction (E-C) coupling is governed by Ca 2؉ release units (CRUs) whereby Ca 2؉ influx via L-type Ca 2؉ channels (Cav1.2) triggers Ca 2؉ release from juxtaposed Ca 2؉ release channels (RyR2) located in junctional sarcoplasmic reticulum (jSR). Although studies suggest that the jSR protein triadin anchors cardiac calsequestrin (Casq2) to RyR2, its contribution to E-C coupling remains unclear. Here, we identify the role of triadin using mice with ablation of the Trdn gene (Trdn ؊/؊ ). The structure and protein composition of the cardiac CRU is significantly altered in Trdn ؊/؊ hearts. jSR proteins (RyR2, Casq2, junctin, and junctophilin 1 and 2) are significantly reduced in Trdn ؊/؊ hearts, whereas Cav1.2 and SERCA2a remain unchanged. Electron microscopy shows fragmentation and an overall 50% reduction in the contacts between jSR and T-tubules. Immunolabeling experiments show reduced colocalization of Cav1.2 with RyR2 and substantial Casq2 labeling outside of the jSR in Trdn ؊/؊ myocytes. CRU function is impaired in Trdn ؊/؊ myocytes, with reduced SR Ca 2؉ release and impaired negative feedback of SR Ca 2؉ release on Cav1.2 Ca 2؉ currents (ICa). Uninhibited Ca 2؉ influx via ICa likely contributes to Ca 2؉ overload and results in spontaneous SR Ca 2؉ releases upon ␤-adrenergic receptor stimulation with isoproterenol in Trdn ؊/؊ myocytes, and ventricular arrhythmias in Trdn ؊/؊ mice. We conclude that triadin is critically important for maintaining the structural and functional integrity of the cardiac CRU; triadin loss and the resulting alterations in CRU structure and protein composition impairs E-C coupling and renders hearts susceptible to ventricular arrhythmias.
T he cardiac Ca 2ϩ release unit (CRU) is a multiprotein complex whose principle components include L-type Ca 2ϩ channels (Cav1.2) juxtaposed to ryanodine receptor Ca 2ϩ release channels (RyR2) (1) . In cardiac excitation-contraction (E-C) coupling, Ca 2ϩ current (I Ca ) via Cav1.2 triggers sarcoplasmic reticulum (SR) Ca 2ϩ release through RyR2 release channels, a process that is highly regulated by RyR2-associated proteins and RyR2 phosphorylation (2) . Among the CRU proteins, RyR2, triadin, junctin, and cardiac calsequestrin (Casq2) form a protein complex located in the junctional elements of the sarcoplasmic reticulum (jSR) (3) . Triadin is encoded by the Trdn gene (4), which produces several isomeric forms that differ in size (5) . Among these, the triadin-1 isoform is predominant in cardiac muscle (6) . Triadin-1 has a membrane-spanning domain, a short cytoplasmic N-terminal segment, and a long, positively charged C-terminal domain extending into the lumen of the SR, which also contains the putative binding domain for Casq2 (6) .
Although the function of cardiac triadin-1 is not explicitly known, attempts have been made to understand its physiologic role in cardiac muscle using acute adenoviral (7) and transgenic overexpression (8) and by reconstitution experiments in lipid bilayers (9) . Changes in expression of triadin-1 are frequently accompanied by altered expression of its binding partners RyR2 (10), Casq2 (11) , and junctin (10) . The trimeric complex of Casq2, triadin-1, and junctin is thought to regulate SR Ca 2ϩ release (9, 12) . Deletion (11) or even modest reductions (13) in Casq2 protein increases diastolic SR Ca 2ϩ leak and causes spontaneous SR Ca 2ϩ release (SCR) and catecholaminergic cardiac arrhythmia. Deletion of junctin enhances SR Ca 2ϩ cycling and contractility but is associated with delayed afterdepolarization-induced ventricular arrhythmias and premature death under conditions of physiologic stress (14) .
To better understand the physiologic role of triadin-1 in the mammalian heart, we performed a comprehensive structural and functional evaluation of the pan triadin null (Trdn Ϫ/Ϫ ) mouse model. We found that triadin-1 is critically important to maintain the structural and functional integrity of the cardiac CRU, which is pivotal for both E-C coupling and maintaining a regular heart rhythm in mammalian hearts.
Results

Triadin-1 Deletion Reduces Expression of jSR Proteins.
The generation of Trdn Ϫ/Ϫ mice and characterization of their skeletal muscle phenotype has been described previously (15) . Here we report the cardiac phenotype of Trdn Ϫ/Ϫ mice. As expected (6) , the immunoreactive 35/40-kDa doublet corresponding to the unglycosylated and glycosylated triadin-1 is absent in Trdn Ϫ/Ϫ microsomes (Fig. 1A) . A 92-kDa immunoreactive protein, tentatively identified as the putative triadin-3 (6) , was also present in Trdn Ϫ/Ϫ microsomes, further challenging the identity of this immunoreactive band as a Trdn-related protein (ref. 16 and Fig.  1 A) . Thus, on the basis of our data the 92-kDa band represents nonspecific binding of the antibody, and triadin-1 is the only triadin isoform that is detectable in murine myocardium.
SR proteins located in the jSR cisternae (RyR2, Casq2, junctin, and junctophilin 1 and 2) were all significantly decreased in Trdn Ϫ/Ϫ hearts ( Fig. 1 B and C) . Expression levels of the SR Ca 2ϩ uptake pump, SERCA2a ( Fig. 1 B and C) and phospholamban (data not shown) located in the free SR domain were not changed. Consistent with the reduction of RyR2 protein (Fig.  1B) (Fig.  S1 ). The K D of neither radioligand was altered due to triadin-1 deletion. Thus, triadin-1 deletion caused significant reductions in RyR2 and associated jSR proteins without significant change in Cav1.2 expression in the plasma membrane.
Loss of Triadin-1 Alters the Architecture of Cardiac CRUs. In mammalian myocardium, RyR2, Casq2, triadin, junctin, and junctophilin are all located in terminal SR cisternae, where the jSR comes in close contact with either the plasma membrane (peripheral coupling) or the T-tubules (dyads), at the level of Z-lines. Together with juxtaposed Cav1.2 channels in the plasmalemma, jSR cisternae form the cardiac CRU.
Analysis of electron micrographs demonstrates that jSR cisternae were less frequent and had shorter RyR2-bearing junctional contacts with T-tubules ( Fig. 1 D and E and Table 1) . Overall, the reduced number and shorter contacts resulted in Ϸ56% reduction in total extent of RyR2-bearing jSR cisternae (Table 1) , in good agreement with the 50% reduction in RyR2 protein measured by Western blot (Fig. 1C) . At the same time, the remaining jSR cisternae were more variable in width and significantly wider in Trdn Ϫ/Ϫ hearts ( Fig. 1E and Table 1 ). Casq2 was visible in the form of small condensed nodules in Trdn ϩ/ϩ (Fig. 1D ) but was barely noticeable, showing only as a The images were selected to illustrate 2 major differences between ϩ/ϩ and Ϫ/Ϫ myocytes: The junctional SR domains of Ϫ/Ϫ myocytes are less extensive and have an increased width. Not shown is the result that jSR profiles are also less frequent in Ϫ/Ϫ myocytes. The combination of less-frequent and smaller contact areas results in a decrease of approximately 50% in areas occupied by RyR2 (see Table 1 ). Fig. 1 C and D) . jSR extent (where feet are located) was obtained by multiplying the jSR contact length (column 2) by the frequency of dyads (ϭ jSR contacts per intermyofibrillar space (IMS), column 3). jSR extent was reduced by 56% in the Trdn Ϫ/Ϫ myocardium. Data are mean Ϯ SD. All data are from 3 mice. In parenthesis are the number of dyads (columns 1 and 2) and number of images (column 3). * , P Ͻ 0.001, Student's t test. diffuse density, in the Trdn Ϫ/Ϫ jSR (Fig. 1E ). There was no significant widening of the free SR elements and no change in total SR volume (data not shown).
We next examined whether loss of triadin-1 also changes the relative positioning of 3 key CRU proteins. Immunolabeling of isolated ventricular myocytes from Trdn ϩ/ϩ mice with anti-RyR2 antibody (red) and anti-Cav1.2 antibody (green) shows welldefined and colocalized (white) foci located at the Z-lines corresponding to dyads ( Fig. 2A) . In Trdn Ϫ/Ϫ myocytes, the degree of colocalization of Cav1.2 with RyR2 was significantly reduced (Fig. 2 B and E) . The non-colocalized Cav1.2 are part of either CRUs with reduced RyR2 content or nonfunctional CRUs lacking RyR2. Immunolabeling with anti-RyR2 and antiCasq2 antibodies shows the dyadic colocalization of both proteins in Trdn ϩ/ϩ myocytes (Fig. 2C) . The degree of colocalization of RyR2 with Casq2 was not significantly different in Trdn Ϫ/Ϫ myocytes, but colocalization of Casq2 with RyR2 was significantly reduced (Fig. 2 D and E ). These data demonstrate that although some Casq2 protein is retained in jSR cisternae, a significant fraction of the Casq2 protein moves into longitudinal SR.
Triadin-1 Deletion Impairs Cardiac E-C Coupling. For cardiac E-C coupling, I Ca through Cav1.2 is required to trigger Ca 2ϩ release (17) . As would be predicted by our ligand-binding studies (Fig.  S1 ), I Ca amplitude was not significantly different in Trdn Ϫ/Ϫ compared with Trdn ϩ/ϩ myocytes under control conditions (Fig.  3A) . However, I Ca inactivation was significantly slower in Trdn Ϫ/Ϫ myocytes (Fig. 3B ). I Ca inactivation is both voltage and Ca 2ϩ dependent (18) . Because of the close proximity of RyR2 and Cav1.2 in the dyad, Ca 2ϩ released from the SR mediates a large fraction of Ca 2ϩ -dependent I Ca inactivation (19) . Given that there are fewer RyR2 channels in Trdn Ϫ/Ϫ hearts ( Fig. 1B and Fig. S1 ), a substantial fraction of Cav1.2 channels are not associated with RyR2 (Fig. 2E) , and the differences in I ca inactivation could be the result of impaired negative feedback on I ca from SR Ca 2ϩ release. Consistent with this idea, preventing SR Ca 2ϩ release by blocking RyR2 channels with ryanodine abolished the differences in I ca inactivation (Fig. 3B) . Incubating myocytes for 30 min with 2 M thapsigargin, which empties SR Ca 2ϩ stores by blocking SR Ca 2ϩ uptake, also abolished the differences in I Ca inactivation time constants [tau at 0 mV (ms): Trdn ϩ/ϩ : 62 Ϯ 2.36, n ϭ 9 vs. Trdn Ϫ/Ϫ : 65.21 Ϯ 2.57, n ϭ 12; P ϭ 0.36).
In ventricular myocytes, ␤-adrenergic receptor stimulation with isoproterenol (ISO) significantly increases I Ca amplitude and accelerates I Ca inactivation, in part by increasing the SR Ca 2ϩ content and release (ref. 19 and Fig. 3C , Left). Ryanodine pretreatment further enhances I Ca peak current amplitude in ISO-stimulated Trdn ϩ/ϩ myocytes, because large SR Ca 2ϩ releases can curtail peak I Ca (ref. 20 and Fig. 3C , Left). In Trdn Ϫ/Ϫ myocytes, ISO caused a greater percentage increase in I Ca amplitude ( Fig. 3C ) than in Trdn ϩ/ϩ myocytes, which was accompanied by very slow I Ca inactivation ( Fig. 3 C and D) . Ryanodine pretreatment abolished the differences in I Ca amplitude between the 2 groups ( Fig. 3C ), but both activation and inactivation of I Ca remained significantly slower in Trdn Ϫ/Ϫ myocytes ( Fig. 3D) . Similar results were obtained in thapsigargin-treated myocytes (data not shown). Thus, although the difference in ISO-stimulated I Ca amplitude can be explained by the reduced negative feedback from SR Ca 2ϩ release, a component of I Ca inactivation is independent of Ca 2ϩ release. To test whether channel gating is altered, we used Ba 2ϩ as a charge carrier, which does not trigger SR Ca 2ϩ release and does not cause Ca 2ϩ -dependent inactivation (19) . Although not different in control conditions (data not shown), in the presence of ISO, both activation and inactivation of I Ba had significantly slower kinetics in Trdn Ϫ/Ϫ compared with Trdn ϩ/ϩ myocytes (Fig. S2 ). We next examined the consequences of triadin deletion and CRU remodeling on SR Ca 2ϩ release and storage. The amplitude and rate of SR Ca 2ϩ release was significantly reduced in Trdn Ϫ/Ϫ compared with Trdn ϩ/ϩ myocytes (Fig. 4 A-C) . ISO abolished the differences in Ca 2ϩ transient amplitude (Fig. 4 A  and B) , but the rate of SR Ca 2ϩ release remained significantly slower in Trdn Ϫ/Ϫ compared with Trdn ϩ/ϩ myocytes (Fig. 4C ). Diastolic Ca 2ϩ (Fig. 4D ) and SR Ca 2ϩ content (Fig. 4 A and E) were significantly increased in Trdn Ϫ/Ϫ compared with Trdn ϩ/ϩ myocytes. Consistent with the decreased colocalization of Cav1.2 and RyR2 channels (Fig. 2E) , the fraction of SR Ca 2ϩ content released in response to a steady-state field stimulus (ϭ fractional release) was significantly reduced in Trdn Ϫ/Ϫ myocytes (Fig. 4F) . Together with the finding that I Ca of Trdn Ϫ/Ϫ myocytes was not different in control conditions (Fig. 3A) and that it increased in the presence of ISO (Fig. 3C) (22) . On the other hand, because triadin-1 reportedly sensitizes the CRU to luminal Ca 2ϩ (7, 9) , triadin-1 deletion may prevent SCR even under conditions of high SR Ca 2ϩ load observed in Trdn Ϫ/Ϫ myocytes. The net effect of Ca 2ϩ overload in myocytes lacking triadin was an increased incidence of SCRs during ISO exposure ( Fig. 5 A and  B) . Conducting the ISO challenge in quiescent myocytes without field stimulation (SCR/min: Trdn ϩ/ϩ 13 Ϯ 2.8, n ϭ 41 vs. Trdn Ϫ/Ϫ 11.8 Ϯ 2.9, n ϭ 32; P ϭ 0.64) or pretreatment with nifedipine (20 M) abolished the differences in SCR incidence between the 2 groups (Fig. 5B) . We next studied global cardiac function in vivo (Table S1 ). Trdn Ϫ/Ϫ mice had increased cardiac contractility measured by echocardiography. Heart/body weight ratio of Trdn Ϫ/Ϫ mice was increased by 26% (P Ͻ 0.001). Histologic analysis of ventricular sections did not reveal any evidence for fibrosis, inflammation, myofibrillar disarray, or myocyte hypertrophy in Trdn Ϫ/Ϫ hearts (data not shown). Electrocardiogram (ECG) evaluation demonstrated significant sinus bradycardia, increased P-wave amplitude, and widened QRS complex, but normal repolarization parameters (Table S1 ). Upon ISO challenge, Trdn Ϫ/Ϫ mice displayed a significantly higher rate of ventricular ectopy and nonsustained ventricular tachycardia than Trdn ϩ/ϩ mice ( Fig. 5  C and D) . Taken together, these results suggest that the structural remodeling of the dyad coupled with myocyte Ca 2ϩ overload as a result of impaired Ca 2ϩ -dependent inactivation of Cav1.2 was sufficient to cause stress-induced ventricular tachycardia in Trdn Ϫ/Ϫ mice.
Discussion
Our results indicate that cardiac triadin-1 is critically important for maintaining the structural integrity of the cardiac CRU. The absence of triadin-1 leads to a loss of dyads and to a reduction in the size of T-tubule-jSR contacts. The structural abnormalities are accompanied by reduction of jSR proteins located in the dyad. The CRU remodeling significantly impaired Ca 2ϩ releasedependent inactivation of Cav1.2, resulting in myocyte Ca 2ϩ overload and SCR events, and ventricular arrhythmias in vivo. Although it is difficult to know which functional changes are caused directly by the absence of Trdn and which are consequences of secondary changes such as the CRU remodeling, our results clearly suggest that TRDN should be considered as a candidate gene for arrhythmia susceptibility in humans.
The mechanism that underlies the Trdn-linked arrhythmia phenotype is surprisingly different from that of genes associated with catecholaminergic ventricular tachycardia (11, 13) . Unlike ventricular tachycardia caused by Casq2 or RyR2 mutations, which cause SR Ca 2ϩ leak and triggered beats at normal or decreased SR Ca 2ϩ load (11), deletion of triadin-1 increases the frequency of SCRs and extra beats by increasing SR Ca 2ϩ content. We speculate that the dramatically reduced feedback inhibition of I Ca by SR Ca 2ϩ release caused a net increase of Ca 2ϩ influx into the cell. Consistent with this hypothesis, I Ca inhibition with nifedipine prevented excessive Ca 2ϩ loading of the SR and the resultant SCRs. Furthermore, although not tested here, it is possible that slow inactivation of I Ca contributed to the high incidence of ventricular ectopy via generation of early afterdepolarizations (23) . Our data suggest that 2 mechanisms exist whereby absence of triadin-1 impairs I Ca inactivation, resulting in myocyte Ca 2ϩ overload. First, the dyadic membranes within Trdn Ϫ/Ϫ cardiomyocytes exhibit an altered architecture, with a reduced colocalization of Cav1.2 with RyR2 channels according to our electron microscopy, immunolabeling, and ligand-binding results. We hypothesize that these structural changes reduce the negative feedback that SR Ca 2ϩ release normally exerts on I ca (19) , given that most differences in I Ca can be prevented by block of SR Ca 2ϩ release with ryanodine or depletion of Ca 2ϩ stores with thapsigargin. A second component of I Ca inactivation remains insensitive to SR Ca 2ϩ release inhibition and is observed even when Ba 2ϩ was used as charge carrier, suggesting that Cav1.2 channel gating properties are altered independently of RyR2 activity and the filling state of SR. Interestingly, altered channel gating is only evident in ISO-stimulated Trdn Ϫ/Ϫ myocytes. It is possible that Cav1.2 channels located outside of dyads exhibit different gating properties, and/or that these channels are nonconducting unless activated by ISO. Whether disruption of a form of bidirectional signaling between Cav1.2 and RyR2 could have contributed to the differences in channel gating remains to be explored. Weak conformational coupling between these proteins has been proposed (24) but remains elusive in cardiac muscle. Other possibilities include enhanced I Ca mode 2 gating (25), altered subunit composition favoring I Ca facilitation (26), or CaMKII-mediated I Ca facilitation (27) , although intact SR Ca 2ϩ release is reportedly required for the latter (27) .
It has been previously shown that overexpression of triadin-1 sensitizes RyR2 channels, increases E-C coupling gain, and causes SCR (7) . According to these studies, loss of triadin-1 should desensitize the SR-release complex and decrease E-C coupling efficiency. Although Trdn Ϫ/Ϫ myocytes exhibited impaired SR Ca 2ϩ release, the altered jSR anatomy (50% reduction in the extent of junctional contacts between SR and T-tubules) is likely to be a major contributor. The increased rate of SCR observed here is not consistent with a primary effect of RyR2 desensitization (22) but more likely the consequence of the increased SR Ca 2ϩ content observed in Trdn Ϫ/Ϫ myocytes. However, our experiments do not rule out that loss of triadin-1 desensitized the RyR2 complex (9) . The concomitant reduction in Casq2 that occurs in Trdn Ϫ/Ϫ myocytes may offset any modulation of RyR2 activity imparted by the lack of triadin-1 (9, 13). The net effect on intrinsic RyR2 activity will have to be addressed by direct measurements of RyR2 function.
Triadin and junctin reportedly anchor Casq2 to RyR2 (3, 6, 28) . In the presence of the 2 proteins Casq2 is restricted to the jSR cisternae and arranged in small clusters (29) . The less dense configuration of Casq2 in the jSR lumen and the partial movement of Casq2 into the free SR are consistent with the drastic reduction in junctin and complete loss of triadin-1 in Trdn Ϫ/Ϫ myocytes. Overall, the structural analysis indicates a much looser association of Casq2 with the RyR2 complex. Although the functional significance of these changes remains to be explored, it may decrease the rate of Ca 2ϩ diffusion within the SR lumen and thereby contribute to the slow rate of Ca 2ϩ release observed in Trdn Ϫ/Ϫ myocytes. The presence of Casq2 in the free SR lumen is not easily detected in electron micrographs, probably because Casq2 concentration is relatively low and thus it does not form a gel of the type seen when Casq2 is overexpressed (30) . The second effect of Trdn deletion, the fragmentation of the jSR cisternae and the resulting decrease in jSR-T-tubule contacts and decreased Cav1.2-RyR2 colocalization, may be the result of a decrease in junctophilin 1 and 2 rather than a direct effect of triadin absence. By partially uncoupling Cav1.2 from RyR2, this configuration change may be the one with the strongest functional effect, as discussed above. The underlying mechanism of how loss of triadin causes a reduction in the jSR proteins will have to be determined in future studies.
A recent report showed a dramatic downregulation of junctin (below level of detection) and triadin (22%) in human failing hearts (31) . Downregulation of triadin-1 in human heart failure may contribute to the decreased E-C coupling efficiency observed in models of heart failure (32) . Surprisingly, despite decreased Ca 2ϩ transients and contractility of individual myocytes, fractional left ventricular shortening was increased in anesthetized Trdn Ϫ/Ϫ mice. Several factors likely contributed to enhanced contractility in vivo: absence of heart fibrosis and myocyte hypertrophy suggests that myocyte hyperplasia may increase the muscle mass of Trdn Ϫ/Ϫ hearts, which would offset hypocontractility at the individual myocyte level. Circulating catecholamines may further enhance contractility in vivo, considering that in individual ISO-stimulated Trdn Ϫ/Ϫ myocytes, Ca 2ϩ transients and contractility were not different from wildtype myocytes. Finally, the slower heart rate of Trdn Ϫ/Ϫ mice allows increased left ventricular filling during diastole, which would increase apparent left ventricular fractional shortening regardless of intrinsic myocardial contractility (33) .
We conclude that ablation of the jSR protein triadin causes susceptibility to ventricular arrhythmias in mice. The underlying mechanism for the arrhythmia phenotype seems to be the structural remodeling of the cardiac Ca 2ϩ release unit, which results in impaired E-C coupling and impaired contractility at the level of the myocyte. Although catecholamines can normalize contractile function by increasing I Ca and SR Ca 2ϩ content, it comes at the price of an increased risk for spontaneous Ca 2ϩ releases in myocytes and triggered ventricular arrhythmias in vivo.
Methods
Animal Model. The use of animals in this study was in accordance to National Institutes of Health guidelines and approved by the Vanderbilt University Laboratory Animal Care and Use Committee. Sex-matched Trdn ϩ/ϩ and Trdn Ϫ/Ϫ mice, C57/black6 strain, of 4 -7 months of age were used for all of the experiments.
Protein Analysis. Mouse ventricular homogenates and microsomes were prepared, immunoblotted ,and quantified as previously described (11); see also SI Methods.
Electron Microscopy. Hearts from 6 -7-month-old Trdn ϩ/ϩ and Trdn Ϫ/Ϫ mice were harvested, the aorta cannulated, and hearts fixed by retrograde reperfusion with 3% glutaraldehyde in 0.1 M sodium cacodylate buffer, pH 7.2. Hearts were processed, imaged by electron microscopy, and estimates of relative surface areas and volumes of the total obtained as previously described (11), with a factor of 2 correction. Lengths and widths of the jSR cisternae profiles were measured with Photoshop (Adobe Systems). All quantitative data were obtained from 3 hearts each for Trdn ϩ/ϩ and Trdn Ϫ/Ϫ mice.
Heart Histology. Hearts were harvested from 6 age-and sex-matched mice per genotype, fixed, sectioned, stained, and the amount of inflammation, cell hypertrophy, myofiber disarray, and fibrosis quantified by an experienced pathologist blinded to the genotype; see also SI Methods.
Immunolabeling and Colocalization Experiments. Isolated ventricular myocytes were used for fixation, permeabilization, and immunolabeling, as well as processing, deconvolving, and analyzing images as previously described (34); see also SI Methods.
Myocyte Isolation and Ca 2؉ Fluorescence Measurements. Single ventricular myocytes were isolated, loaded with the membrane-permeable fluorescent Ca 2ϩ indicator Fura-2 AM, and [Ca 2ϩ ] measured as previously described (11); see also SI Methods.
Analysis of SCRs.
An SCR was defined as any spontaneous increase of 0.1 ratiometric units (3 times the average background noise) or more from the diastolic Fratio other than when triggered by field stimulation or caffeine (11) . For each myocyte, SCRs were counted over a 20-s period. SCRs and SR Ca 2ϩ content were also analyzed in myocytes after 20-min incubation with the Cav1.2 channel blocker nifedipine 20 M.
Voltage-Clamp Studies. Cav1.2 Ca 2ϩ currents were measured as previously described (11); see also SI Methods.
ECG Recordings and Echocardiography. For the surface ECG and echocardiography, recordings were done as previously described (11) . ISO challenge was performed on unrestrained telemetry-implanted mice as described previously (11) .
Statistical Analysis. All experiments were done in random sequence with respect to the genotype, and measurements were taken by a single observer who was blinded to the genotype. Differences between groups were assessed using a one-way analysis of variance (for normally distributed parameters) or by Kruskal-Wallis test (for parameters that are not normally distributed). If statistically significant differences were found, individual groups were compared with Student's t test or by nonparametric tests, as indicated in the text. Results were considered statistically significant if the P value was Ͻ0.05. Unless otherwise indicated, results are expressed as arithmetic means Ϯ SEM. Protein Analysis. Mouse ventricular homogenates and microsomes were prepared as previously described (1) . Immunoblotting against RyR2, Serca2a, Casq2, triadin, and junctin was conducted with antibodies as described previously (1) . Antibodybinding protein bands were visualized with 125 I-protein A and then quantified using a Bio-Rad Personal Fx phosphorimager. Quantitative immunoblotting for junctophilin 1 and 2 was performed using the Odyssey Infrared Imaging System (Li-COR Biosciences). The custom-made antibodies were kindly provided by Dr. H. Takeshima (2) .
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Electron Microscopy. Hearts from 6-7-month-old Trdn ϩ/ϩ and Trdn Ϫ/Ϫ mice were harvested, the aorta cannulated, and hearts fixed by retrograde reperfusion with 3% glutaraldehyde in 0.1 M sodium cacodylate buffer, pH 7.2. Hearts were processed, imaged by electron microscopy, and estimates of relative surface areas and volumes of the total obtained as previously described (3), with a factor of 2 correction. Lengths and widths of the jSR cisternae profiles were measured with Photoshop (Adobe Systems). All quantitative data were obtained from 3 hearts each for Trdn ϩ/ϩ and Trdn Ϫ/Ϫ mice.
Heart Histology. Hearts were harvested from 6 age-and sexmatched mice per genotype, fixed by perfusion with 10% buffered formaldehyde, and embedded in paraffin. A total of 24 transverse sections (4-m thickness) were cut from each heart, with the first section at the level of the papillary muscle Ϸ2 mm below the mitral valve. Twelve sections were stained with hematoxylin and eosin and examined for the amount of inflammation present, individual cell hypertrophy, and myofiber disarray. The other 12 were stained with Masson's trichrome and evaluated for fibrosis. For each category, the histology was graded on a scale from 0 to 3 by an experienced pathologist blinded to the genotype.
Immunolabeling and Colocalization Experiments. Isolated ventricular myocytes from Trdn ϩ/ϩ and Trdn Ϫ/Ϫ mice were used. The techniques for fixation, permeabilization, and immunolabeling, as well as processing, deconvolving, and analyzing images have been previously described (4, 5) . We used an anti-RyR2 monoclonal antibody and a polyclonal anti-CSQ from Affinity Bioreagents, as well as an affinity-purified rabbit polyclonal antibody against the pore-forming subunit of the voltage-gated calcium channel, Cav1.2 (6) . The secondary antibodies were affinity purified and highly cross-adsorbed goat antimouse conjugated to Alexa 594 and goat antirabbit conjugated to Alexa 488 (Invitrogen). Images were acquired using an inverted Zeiss Axio Observer microscope equipped with a Plan Apo 63/1.4 objective and EXFO Xcite illumination. All filters were from Semrock.
Myocyte Isolation and Ca 2؉ Indicator Loading. Single ventricular myocytes were isolated by a modified collagenase/protease method as previously described (7) . All chemicals, unless otherwise specified, were obtained from Sigma. Ventricular myocytes were incubated with 2 M fura-2 acetoxymethyl ester (Fura-2 AM; Molecular Probes) for 8 min at room temperature to load the indicator in the cytosol. Myocytes were then washed twice for 10 min with 1.2 mM Ca 2ϩ Tyrode's solution (TS) containing 250 M probenecid to retain the indicator in the cytosol. A minimum of 30 min were allowed for de-esterification of the indicator before imaging the cells. All of the experiments were then conducted in 2 mM Ca 2ϩ TS. The composition of TS was (in mM): NaCl, 134; KCl, 5.4; MgCl 2 , 1; glucose, 10; and Hepes, 10, pH adjusted to 7.4 with NaOH.
Ca 2؉ Fluorescence Measurements. Fura-2-loaded healthy rodshaped isolated ventricular myocytes were loaded in the experimental chamber, field-stimulated, and superfused with TS containing 2 mM Ca 2ϩ . Intracellular Ca 2ϩ transients were measured using a dual-beam excitation fluorescence photometry setup (IonOptix). After 5-10 min of steady-state pacing at 1 Hz, 4 10-s Ca 2ϩ fluorescence records were obtained from each myocyte. After that, myocytes were exposed for 4 s to TS containing 10 mM caffeine using a rapid concentration clamp system. The amplitude of the caffeine-induced Ca 2ϩ transient was used as estimates of total SR Ca 2ϩ content (8) . All experiments were conducted at room temperature (Ϸ23°C). Where indicated, ISO was used at a concentration of 1 M. Ca Analysis of SCRs. An SCR was defined as any spontaneous increase of 0.1 ratiometric units (3 times the average background noise) or more from the diastolic F ratio other than when triggered by field stimulation or caffeine (3). For each myocyte, SCRs were counted over a 20-s period. In a separate set of experiments, SCRs and SR Ca 2ϩ content were analyzed in myocytes incubated with the Cav1.2 channel blocker nifedipine 20 M for at least 20 min.
Voltage-Clamp Studies. Cav1.2 Ca 2ϩ currents were measured as previously described (11) . Briefly, mouse ventricular myocytes were whole-cell patched in K ϩ -free solution containing (in mM): NaCl, 137; MgCl2, 1; CaCl, 2; Hepes, 10; glucose, 10; pH 7.4. The pipette solution contained (in mM): CsCl, 110; TEA-Cl, 20; EGTA, 14; Hepes, 10; MgATP, 5; glucose, 10; pH 7.2. Na ϩ currents were eliminated by adding tetrodotoxin (30 M) to external solutions and a holding potential of Ϫ50 mV. I Ca -L was elicited with 200-ms depolarization pulses ranging from Ϫ50 to 40 mV in 10-mV steps. Where indicated, ISO was used at a concentration of 1 M and ryanodine at 10 M.
ECG Recordings and Echocardiography. For the surface ECG and echocardiography, recordings were done as previously described (3, 11, 12) . Isoproterenol challenge was performed on unrestrained telemetry implanted mice as described previously (3).
Measurement of [ 3 H]PN200 -110 and [ 3 H]ryanodine
Binding. Cardiac ventricles were dissected from age-matched Trdn ϩ/ϩ and Trdn Ϫ/Ϫ mice (117-192 days old, 6 hearts per group), snap frozen, and stored at Ϫ80°C. Ventricles were homogenized and membrane vesicles prepared with minor modifications as described by Lachnit et al. (13) Briefly, frozen ventricles were pulverized with a dry ice-cooled mortar and pestle. Equal masses of tissue were suspended in 40 volumes of a cold buffer consisting of 300 mM sucrose, 40 mM histidine, and 40 mM Tris, pH 7.0, supplemented by 20 g/mL PMSF and 10 g/mL leupeptin. Tissue suspensions were placed in an ice bath and homogenized with a PowerGen 700D (Fisher Scientific) set at 18,000 rpm, using 3 30-s cycles with 30 s between each cycle. Tissue homogenate was then centrifuged at 45,000 ϫ g for 30 min. Pellets were resuspended with a Dounce homogenizer in cold buffer consisting of 300 mM sucrose and 5 mM imidazole, pH 7.0. Aliquots were snap-frozen in liquid nitrogen. Protein concentrations were determined with the BCA kit (Pierce). For 3 H]ryanodine and 0-250 nM unlabeled ryanodine (cold titration) for 3 h at 37°C in a buffer consisting of 250 mM KCl, 15 mM KCl, 20 mM Hepes, and 50 M CaCl2, pH 7.1. Binding was quenched by filtration of membranes onto GF/B filters using a cell harvester and washed 3 times with 4 mL of ice-cold wash buffer (250 mM KCl, 10 mM Tris-HCl, and 50 M CaCl2, pH 7.1). Radioactivity was quantified with a Beckman LS 6500 scintillation counter. For data analysis, binding isotherms were fit to a single site model and analyzed with Prism V5.00 software (GraphPad).
Statistical Analysis. All experiments were done in random sequence with respect to the genotype, and measurements were taken by a single observer who was blinded to the genotype. Differences between groups were assessed using a one-way analysis of variance (for normally distributed parameters) or by Kruskal-Wallis test (for parameters that are not normally distributed). If statistically significant differences were found, individual groups were compared with Student's t test or by nonparametric tests as indicated in the text. Results were considered statistically significant if the P value was Ͻ0.05. Unless otherwise indicated, results are expressed as arithmetic means Ϯ SEM. group. ** , P Ͻ 0.01; *** , P Ͻ 0.001. Average cell capacitance, access resistance, and peak IBa were not statistically different between the 2 groups. Table S1 . Echocardiographic and ECG parameters of anesthetized mice
